FDA Approved: ADCIRCA — Supplemental Application (United Therapeutics Corporation)

View source ↗

Summary

The FDA approved a supplemental application for ADCIRCA (tadalafil) submitted by United Therapeutics Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Adcirca (tadalafil)

Snippet

SUPPL AP for ADCIRCA (TADALAFIL)